Tue, Feb 25, 9:02 PM (60 days ago)
SLR HC BDC LLC is a Delaware-based closed-end investment company structured as a BDC and RIC, targeting first lien healthcare cash flow and life science loans in the U.S. middle market. The strategy focuses on private equity-backed healthcare companies and venture capital–backed life science firms, with loan maturities typically spanning 3–6 years. Revenue is mainly derived from interest income, fees (management, incentive, origination, and administrative), and occasional capital gains. The company benefits from co-investment opportunities with related SLR-managed funds, leveraging its capital base for sourcing larger, attractive deals. It must comply with regulatory requirements including maintaining qualifying assets (70% minimum) and distributing at least 90% of taxable income. The text also details extensive risk factors—credit, liquidity, market volatility, cybersecurity, regulatory uncertainties, and economic downturns—that could adversely affect financial performance, operating expenses, and overall market position. Future outlook depends on successful investment execution and navigating evolving market and regulatory challenges, as highlighted by recent amendments affecting borrowing costs and maturities.